The results showed that the survival rate of these cells (PAH–PAECs + Sh-Dec1) declined 25% compared with that of the controlled cells (PAH–PAECs + Sh-Dec1, Figure 3D). The gene discussed is BHLHE40; the disease is pulmonary arterial hypertension.